Nexentis Technologies Inc. (NXTS) stock
NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.75−0.07 (-3.98%)
Close on Nov 18, 2026Market cap $2.54MP/E –Yield –
Nexentis Technologies operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Nexentis Technologies's operating income for the twelve months ending Jun 30, 2026 was -$10.88M. For fiscal 2025 it was -$4.23M. The highest annual figure on record is -$518.66K in fiscal 2018.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$4.23M | – |
| FY2024 | Dec 31, 2024 | -$3.28M | – |
| FY2023 | Dec 31, 2023 | -$7.58M | – |
| FY2022 | Dec 31, 2022 | -$5.82M | – |
| FY2021 | Dec 31, 2021 | -$4.70M | – |
| FY2020 | Dec 31, 2020 | -$1.35M | – |
| FY2019 | Dec 31, 2019 | -$1.93M | – |
| FY2018 | Dec 31, 2018 | -$518.66K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$1.88M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.23M | – |
| Q4 FY2025 | Dec 31, 2025 | $549.00K | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.33M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.63M | – |
| Q1 FY2025 | Mar 31, 2025 | -$503.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$219.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.44M | – |
| Q2 FY2024 | Jun 30, 2024 | -$847.00K | – |
| Q1 FY2024 | Mar 31, 2024 | -$899.00K | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.14M | – |
| Q3 FY2023 | Sep 30, 2023 | -$2.86M | – |
| Q2 FY2023 | Jun 30, 2023 | -$840.32K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.74M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.43M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.77M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.28M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.35M | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.57M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.29M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.62M | – |
| Q1 FY2021 | Mar 31, 2021 | -$246.88K | – |
| Q4 FY2020 | Dec 31, 2020 | -$151.67K | – |
| Q3 FY2020 | Sep 30, 2020 | -$432.09K | – |
| Q2 FY2020 | Jun 30, 2020 | -$403.73K | – |
| Q1 FY2020 | Mar 31, 2020 | -$361.86K | – |
| Q4 FY2019 | Dec 31, 2019 | -$552.36K | – |
| Q3 FY2019 | Sep 30, 2019 | -$504.73K | – |
| Q2 FY2019 | Jun 30, 2019 | -$528.37K | – |
| Q1 FY2019 | Mar 31, 2019 | -$345.84K | – |
See a number that looks wrong?